Spots Global Cancer Trial Database for recurrent pancreatic cancer

Every month we try and update this database with for recurrent pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors	NCT00667641	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu...	bortezomib paclitaxel	18 Years -	Rutgers, The State University of New Jersey
Interleukin-12 in Treating Patients With Cancer in the Abdomen	NCT00003046	Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc...	Recombinant Int...	18 Years -	M.D. Anderson Cancer Center
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer	NCT00274885	Cancer	oxaliplatin management of t...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery	NCT00004003	Pancreatic Canc...	cisplatin fluorouracil gemcitabine hyd...	18 Years -	Barbara Ann Karmanos Cancer Institute
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer	NCT00547612	Pancreatic Canc...	high performanc... pharmacological... [18F]-labeled s...	18 Years -	National Institutes of Health Clinical Center (CC)
Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery	NCT01473940	Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre...	ipilimumab gemcitabine hyd... laboratory biom...	18 Years -	Northwestern University
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery	NCT01537107	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre... Unspecified Adu...	vismodegib sirolimus positron emissi... computed tomogr... pharmacological... laboratory biom... fludeoxyglucose...	18 Years -	Mayo Clinic
BMS-247550 in Treating Patients With Advanced Pancreatic Cancer	NCT00016965	Pancreatic Canc...	ixabepilone	18 Years -	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine	NCT00053222	Pancreatic Canc...	arsenic trioxid...	18 Years -	University of Chicago
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer	NCT02048943	Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unspecified Adu...	dovitinib lacta... gemcitabine hyd... paclitaxel albu... pharmacological... laboratory biom...	18 Years -	Roswell Park Cancer Institute
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas	NCT00005870	Pancreatic Canc...	fluorouracil gemcitabine hyd... mitomycin C rubitecan	18 Years -	National Cancer Institute (NCI)
Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients	NCT00383760	Adenocarcinoma ... Pancreatic Canc... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre...	eribulin mesyla...	18 Years -	National Cancer Institute (NCI)
Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine	NCT00397787	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre...	sunitinib malat...	18 Years -	National Cancer Institute (NCI)
Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors	NCT00352131	Non-colorectal ... Pancreatic Canc...	HuC242-DM4	18 Years -	ImmunoGen, Inc.
Interleukin-12 in Treating Patients With Cancer in the Abdomen	NCT00003046	Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc...	Recombinant Int...	18 Years -	M.D. Anderson Cancer Center
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors	NCT01233505	Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu...	veliparib capecitabine oxaliplatin pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors	NCT00066651	Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton...	SS1(dsFv)-PE38 ...	18 Years -	National Cancer Institute (NCI)
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas	NCT00005870	Pancreatic Canc...	fluorouracil gemcitabine hyd... mitomycin C rubitecan	18 Years -	National Cancer Institute (NCI)
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer	NCT01227018	Adenocarcinoma ... Recurrent Pancr... Stage IV Pancre...	STA-9090 Radiologic imag... blood draw	18 Years -	Vanderbilt-Ingram Cancer Center
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer	NCT00577889	Adenocarcinoma ... Recurrent Pancr... Stage IV Pancre...	gemcitabine hyd... tanespimycin	18 Years -	National Cancer Institute (NCI)
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers	NCT00684801	Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	questionnaire a... quality-of-life...	18 Years -	Case Comprehensive Cancer Center
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer	NCT00003427	Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine...	irinotecan hydr... oxaliplatin	18 Years -	Memorial Sloan Kettering Cancer Center
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	NCT00004895	Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine...	octreotide acet...	18 Years -	Northwestern University
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer	NCT00025532	Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc...	iodine I 131 mo...	19 Years -	University of California, San Francisco
Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer	NCT00810719	Pancreatic Canc...	Erlotinib gemcitabine	18 Years -	University of California, Davis
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum	NCT00005860	Cancer	floxuridine leucovorin calc... oxaliplatin	18 Years -	National Cancer Institute (NCI)
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer	NCT00002475	Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc...	allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid...	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer	NCT00005869	Pancreatic Canc...	gemcitabine hyd... rubitecan	18 Years -	National Cancer Institute (NCI)
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer	NCT00276744	Pancreatic Canc...	cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su...	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer	NCT00964171	Pancreatic Canc...	efavirenz quality-of-life...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer	NCT00266097	Extrahepatic Bi... Gallbladder Can... Pancreatic Canc...	erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin	18 Years -	UNC Lineberger Comprehensive Cancer Center
Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer	NCT00005648	Pancreatic Neop...	Gemcitabine wit... Gemcitabine wit...	18 Years -	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer	NCT00063947	Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr...	erlotinib hydro... gemcitabine hyd... radiation thera... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas	NCT00003797	Pancreatic Canc...	trastuzumab gemcitabine hyd...	18 Years -	National Cancer Institute (NCI)
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer	NCT00544193	Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera...	18 Years - 70 Years	City of Hope Medical Center
Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer	NCT01327794	Pancreatic Canc...	polymorphism an... immunologic tec... laboratory biom... medical chart r...	18 Years -	Alliance for Clinical Trials in Oncology
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders	NCT00830557	Islet Cell Tumo... Pancreatic Canc... Pancreatic Dise...	medical chart r... survey administ... biospecimen col...	18 Years - 120 Years	Mayo Clinic
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT00004095	Bladder Cancer Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Pancreatic Canc...	gemcitabine hyd... irinotecan hydr...	18 Years - 120 Years	Northwestern University
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer	NCT01666730	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre...	metformin hydro... oxaliplatin leucovorin calc... fluorouracil laboratory biom...	18 Years -	Case Comprehensive Cancer Center
Pancreatic Cancer Collaborative Registry	NCT00661882	Pancreatic Canc...	medical chart r... questionnaire a... study of socioe... biopsy	19 Years - 100 Years	University of Nebraska
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer	NCT00276744	Pancreatic Canc...	cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su...	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine	NCT00867126	Pancreatic Canc...	pioglitazone hy... laboratory biom... questionnaire a... quality-of-life...	18 Years - 120 Years	University of Texas Southwestern Medical Center
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer	NCT00010270	Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc...	LMB-9 immunotox...	18 Years -	National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
Irinotecan and Capecitabine in Treating Patients With Solid Tumors	NCT00003867	Cancer	capecitabine irinotecan hydr...	18 Years - 120 Years	Montefiore Medical Center
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer	NCT01927393	Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Stage III Pancr... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre...	palliative care educational int... quality-of-life... questionnaire a... telephone-based...	21 Years -	City of Hope Medical Center
Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer	NCT00331682	Adenocarcinoma ... Recurrent Pancr... Stage IV Pancre...	alvocidib docetaxel	18 Years -	National Cancer Institute (NCI)
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer	NCT00266097	Extrahepatic Bi... Gallbladder Can... Pancreatic Canc...	erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin	18 Years -	UNC Lineberger Comprehensive Cancer Center
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors	NCT00369109	Breast Cancer Colorectal Canc... Pancreatic Canc...	biologic sample... immunohistochem... laboratory biom... biopsy	18 Years -	Barbara Ann Karmanos Cancer Institute
Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride	NCT00981162	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre... Unspecified Adu...	sorafenib tosyl... everolimus laboratory biom... pharmacogenomic... pharmacological...	18 Years -	Roswell Park Cancer Institute
Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer	NCT00019084	Breast Cancer Cervical Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	aldesleukin mutant p53 pept... ras peptide can... sargramostim therapeutic aut... therapeutic tum...	18 Years -	National Cancer Institute (NCI)
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors	NCT00667641	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu...	bortezomib paclitaxel	18 Years -	Rutgers, The State University of New Jersey
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer	NCT01666730	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre...	metformin hydro... oxaliplatin leucovorin calc... fluorouracil laboratory biom...	18 Years -	Case Comprehensive Cancer Center
Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer	NCT02048943	Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unspecified Adu...	dovitinib lacta... gemcitabine hyd... paclitaxel albu... pharmacological... laboratory biom...	18 Years -	Roswell Park Cancer Institute
Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer	NCT00047307	Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre...	alvocidib gemcitabine hyd... 3-dimensional c... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas	NCT00003810	Pancreatic Canc...	docetaxel gemcitabine hyd...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer	NCT00281996	Pancreatic Canc...	Gemcitabine Imatinib mesyla...	18 Years -	Northwestern University
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT00004095	Bladder Cancer Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Pancreatic Canc...	gemcitabine hyd... irinotecan hydr...	18 Years - 120 Years	Northwestern University
Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	NCT00095966	Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre...	sorafenib tosyl... gemcitabine hyd...	18 Years -	National Cancer Institute (NCI)
Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	NCT00088894	Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre...	gemcitabine hyd... bevacizumab placebo laboratory biom... pharmacogenomic... pharmacological...	18 Years -	National Cancer Institute (NCI)
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer	NCT00436410	Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma	colloidal gold-... electron micros... pharmacological... conventional su...	18 Years -	National Institutes of Health Clinical Center (CC)
Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery	NCT00109941	Pancreatic Canc...	opioid growth f... metenkephalin, ...	18 Years - 80 Years	Milton S. Hershey Medical Center
Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer	NCT00091026	Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre...	cetuximab gemcitabine hyd... bevacizumab erlotinib hydro...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery	NCT00004003	Pancreatic Canc...	cisplatin fluorouracil gemcitabine hyd...	18 Years -	Barbara Ann Karmanos Cancer Institute
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer	NCT00027534	Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ...	TRICOM-CEA(6D)	18 Years -	Duke University
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery	NCT00436267	Metastatic Canc... Pancreatic Canc...	fluorouracil selective exter... tomotherapy yttrium Y 90 gl... yttrium Y 90 re...	18 Years -	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer	NCT00087191	Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga...	EF5 motexafin lutet... pharmacological...	18 Years -	National Cancer Institute (NCI)
Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	NCT00448838	Pancreatic Canc...	Cetuximab Gemcitabine Hyd... Oxaliplatin	18 Years - 120 Years	University of Miami
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	NCT00425360	Pancreatic Canc...	sargramostim telomerase pept... capecitabine gemcitabine hyd...	18 Years -	National Cancer Institute (NCI)
Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	NCT01222689	Adenocarcinoma ... Recurrent Pancr... Stage III Pancr... Stage IV Pancre...	erlotinib hydro... selumetinib laboratory biom...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: